Description

Technical Parameters

Introduction

pill

product-1400-1400

Products Description

### Systematic introduction of FIERCE brand Nolvadex capsules 20mg

#### 1. Drug overview

**Nolvadex** (generic name: Tamoxifen) is a selective estrogen receptor modulator (SERM) widely used in the adjuvant treatment and prevention of hormone-sensitive breast cancer. FIERCE brand Nolvadex capsules 20mg is an oral formulation of the drug, known for its high purity, stability and clinical effectiveness. The following systematically analyzes its characteristics from multiple dimensions.

---

#### 2. Drug classification and core features

##### 1. **Pharmacological classification**

- **SERM (selective estrogen receptor modulator)**: Tamoxifen exerts an anti-estrogen effect in breast tissue by binding to estrogen receptors, inhibiting tumor growth; it exhibits estrogen-like activity in the bone and cardiovascular system, protecting bone density and blood lipid metabolism.

- **Anticancer drugs**: Mainly used for preoperative/postoperative adjuvant treatment of estrogen receptor-positive (ER+) breast cancer, and long-term management of metastatic breast cancer.

##### 2. **Dosage form classification**

- **Oral capsule dosage form**: FIERCE brand Nolvadex adopts hard gelatin capsule design to optimize drug release rate and ensure stable gastrointestinal absorption.

- **Dosage specification**: Each capsule contains 20mg of tamoxifen citrate (equivalent to 15.2mg of tamoxifen base), suitable for individualized treatment at different stages.

---

#### 3. Advantages and clinical advantages

##### 1. **High efficiency and targeting**

- **Precise regulation**: High selectivity for estrogen receptors, reducing side effects on non-target organs.

- **Reducing recurrence rate**: Clinical trials have shown that 5 years of postoperative use can reduce the risk of breast cancer recurrence by 50% (NSABP B-14 study).

##### 2. **Tolerability advantage**

- **Controllable side effect spectrum**: Compared with chemotherapy drugs, tamoxifen has lower toxicity such as bone marrow suppression and hair loss, and higher patient compliance.

- **Long-term safety**: More than 40 years of clinical application data support its safety, and severe liver toxicity is rare (incidence <0.1%).

##### 3. **Multi-effect application**

- **Preventive use**: Reduced breast cancer risk in high-risk groups (such as BRCA mutation carriers) (IBIS-I trial).

- **Reproductive medicine application**: Used for ovulation induction treatment and male infertility (off-label use).

---

#### 4. Physical and chemical properties

##### 1. **Chemical structure**

- **Molecular formula**: C₃₂H₃₇NO₃ (tamoxifen base); C₃₂H₃₇NO₃·C₆H₈O₇ (citrate form).

- **Molecular weight**: 563.65 g/mol (base); 751.89 g/mol (citrate).

##### 2. **Solubility characteristics**

- **Fat solubility**: LogP value is about 6.1, highly fat-soluble, and surfactants (such as polysorbate 80) are required to improve the stability of the preparation.

- **pH dependence**: High solubility in acidic environment (pH<3), enteric coating can prevent gastric acid degradation.

##### 3. **Stability parameters**

- **Storage conditions**: It is recommended to store below 25°C away from light and relative humidity <60%.

- **Degradation products**: The main degradation pathway is oxidation to generate N-oxides, and the sealing of the packaging needs to be strictly controlled.

---

#### 5. Color and appearance design

##### 1. **Capsule appearance**

- **Color coding**: FIERCE brand 20mg capsules adopt a two-color design of **white opaque capsule body + dark blue capsule cap**, which complies with international drug identification standards (ISO 11238) for easy identification and prevention of misuse.

- **Marking system**: The capsule body is printed with laser engraved "FIERCE 20" to ensure that it will not fade after long-term use.

##### 2. **Coating technology**

- **Enteric coating**: Double-layer coating of hydroxypropyl methylcellulose (HPMC) and acrylic resin is used to ensure that the drug is released in the alkaline environment of the duodenum and reduce gastric irritation.

---

#### 6. Clinical application and dosage regimen

##### 1. **Indications**

- **Breast cancer treatment**: Postoperative adjuvant therapy for ER+ breast cancer, locally advanced or metastatic breast cancer.

- **Ductal carcinoma in situ (DCIS)**: Reduce the risk of invasive cancer.

##### 2. **Standard dose**

- **Adjuvant therapy**: 20 mg per day for 5-10 years (according to NCCN guidelines).

- **Dose adjustment**: Patients with liver dysfunction need to reduce the dose to 10 mg/day, and severe renal damage does not require adjustment.

---

#### 7. Safety and contraindications

##### 1. **Common side effects**

- **Hot flashes** (incidence 40-50%), **endometrial thickening** (regular ultrasound monitoring is required), **visual abnormalities** (retinopathy is rare but requires vigilance).

##### 2. **Contraindications**

- Pregnancy (FDA classification D), history of deep vein thrombosis, simultaneous use of strong CYP2D6 inhibitors (such as fluoxetine).

---

#### 8. Market and brand positioning

##### 1. **Brand advantages**

- **High bioavailability**: Using nanocrystal dispersion technology (NanoCrystal®), the bioavailability is more than 90%.

- **Environmentally friendly packaging**: aluminum-plastic blister + recyclable paper box, in line with the green medicine initiative of the European Union EMA.

##### 2. **Global Market**

- **Price Range**: About 2-3 USD/pill (depending on regional medical insurance policy differences).

- **Generic Competition**: Compared with AstraZeneca's original drug, FIERCE brand costs 30% less and occupies a major share of emerging markets.

---

#### 9. Future Research Directions

- **Combination Therapy**: Combined with CDK4/6 inhibitors (such as Palbociclib) to enhance efficacy.

- **New Formulation**: Transdermal patch development to reduce first-pass effect.

---

#### Conclusion

FIERCE brand Nolvadex 20mg capsules have become one of the core drugs for endocrine therapy of breast cancer through precise preparation technology and strict quality control system. Its multi-dimensional advantages (from molecular characteristics to clinical efficacy) and humanized design (such as anti-misuse color coding) reflect the outstanding achievements of the modern pharmaceutical industry in balancing efficacy and safety. With the development of personalized medicine in the future, this drug is expected to show greater potential in precise dose adjustment and combination therapy.